A detailed history of Varma Mutual Pension Insurance CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Varma Mutual Pension Insurance CO holds 40,000 shares of BMRN stock, worth $2.57 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
40,000
Previous 30,000 33.33%
Holding current value
$2.57 Million
Previous $2.47 Million 13.85%
% of portfolio
0.03%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $690,200 - $938,400
10,000 Added 33.33%
40,000 $2.81 Million
Q1 2024

May 13, 2024

SELL
$83.81 - $99.0 $1.68 Million - $1.98 Million
-20,000 Reduced 40.0%
30,000 $2.62 Million
Q4 2023

Feb 13, 2024

SELL
$76.22 - $98.51 $3.81 Million - $4.93 Million
-50,000 Reduced 50.0%
50,000 $4.82 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $3.47 Million - $4.01 Million
-40,000 Reduced 28.57%
100,000 $8.67 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $2.88 Million - $3.39 Million
35,000 Added 33.33%
140,000 $11.9 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $5.94 Million - $7.42 Million
80,000 Added 320.0%
105,000 $8.1 Million
Q4 2020

Feb 09, 2021

SELL
$72.61 - $90.2 $1.82 Million - $2.26 Million
-25,000 Reduced 50.0%
25,000 $2.19 Million
Q3 2020

Nov 04, 2020

SELL
$71.87 - $131.03 $5.75 Million - $10.5 Million
-80,000 Reduced 61.54%
50,000 $3.8 Million
Q2 2020

Aug 11, 2020

BUY
$79.55 - $124.22 $3.98 Million - $6.21 Million
50,000 Added 62.5%
130,000 $16 Million
Q1 2020

May 11, 2020

BUY
$71.37 - $96.85 $2.14 Million - $2.91 Million
30,000 Added 60.0%
80,000 $6.76 Million
Q4 2019

Feb 06, 2020

BUY
$64.27 - $86.37 $3.21 Million - $4.32 Million
50,000 New
50,000 $4.23 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Varma Mutual Pension Insurance CO Portfolio

Follow Varma Mutual Pension Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Varma Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Varma Mutual Pension Insurance CO with notifications on news.